<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lipitz-Snyderman A</submitter><funding>NCI NIH HHS</funding><funding>Memorial Sloan Kettering Cancer Center</funding><funding>United Hospital Fund</funding><pagination>4728-4736</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7539686</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>123(23)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Patient safety is a critical concern in clinical oncology, but the ability to measure adverse events (AEs) across cancer care is limited by a narrow focus on treatment-related toxicities. The objective of this study was to assess the nature and extent of AEs among cancer patients across inpatient and outpatient settings.&lt;h4>Methods&lt;/h4>This was a retrospective cohort study of 400 adult patients selected by stratified random sampling who had breast (n = 128), colorectal (n = 136), or lung cancer (n = 136) treated at a comprehensive cancer center in 2012. Candidate AEs, or injuries due to medical care, were identified by trained nurse reviewers over the course of 1 year from medical records and safety-reporting databases. Physicians determined the AE harm severity and the </pubmed_abstract><journal>Cancer</journal><pubmed_title>Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.</pubmed_title><pmcid>PMC7539686</pmcid><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>P30 CA 008748</funding_grant_id><pubmed_authors>Classen D</pubmed_authors><pubmed_authors>Atoria CL</pubmed_authors><pubmed_authors>Lipitz-Snyderman A</pubmed_authors><pubmed_authors>Weingart SN</pubmed_authors><pubmed_authors>Anderson C</pubmed_authors><pubmed_authors>Fortier E</pubmed_authors><pubmed_authors>Killen A</pubmed_authors><pubmed_authors>Pfister D</pubmed_authors><pubmed_authors>Epstein AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.</name><description>&lt;h4>Background&lt;/h4>Patient safety is a critical concern in clinical oncology, but the ability to measure adverse events (AEs) across cancer care is limited by a narrow focus on treatment-related toxicities. The objective of this study was to assess the nature and extent of AEs among cancer patients across inpatient and outpatient settings.&lt;h4>Methods&lt;/h4>This was a retrospective cohort study of 400 adult patients selected by stratified random sampling who had breast (n = 128), colorectal (n = 136), or lung cancer (n = 136) treated at a comprehensive cancer center in 2012. Candidate AEs, or injuries due to medical care, were identified by trained nurse reviewers over the course of 1 year from medical records and safety-reporting databases. Physicians determined the AE harm severity and the </description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Dec</publication><modification>2025-04-04T23:54:57.305Z</modification><creation>2020-10-29T08:14:12Z</creation></dates><accession>S-EPMC7539686</accession><cross_references><pubmed>28817180</pubmed><doi>10.1002/cncr.30916</doi></cross_references></HashMap>